Rocket Pharmaceuticals logo
Rocket Pharmaceuticals RCKT
$ 18.46 4.89%

Quarterly report 2024-Q2
added 08-06-2024

report update icon

Rocket Pharmaceuticals Operating Income 2011-2024 | RCKT

Annual Operating Income Rocket Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-260 M -224 M -167 M -134 M -76.2 M -71.2 M -19.8 M -7.57 M -20.4 M -7.7 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-7.57 M -260 M -98.8 M

Quarterly Operating Income Rocket Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-73.7 M -67.4 M - -65.4 M -68.8 M -62.2 M - -58.5 M -54.2 M -42.6 M - -49.6 M -34 M -39.2 M -59.2 M -27.4 M -23.6 M -24.1 M -19.6 M -19.2 M -18.4 M -18.9 M -26.5 M -15.3 M -14.9 M -14.4 M -6.66 M -6.72 M -3.52 M -2.87 M - -10.7 M -8.78 M -10.1 M - -5.44 M -3.68 M -3.05 M - -2.09 M -2.19 M -1.71 M - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-1.71 M -73.7 M -26.8 M